Internal Medicine, Rheumatology · Cedar Rapids, IA
NPI
1588653877
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
202 10th Street SE
Cedar Rapids, IA, 52403
Phone (319) 398-1546
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
247,806 services
Medicare patients, 2024
526
Average age 74
Drug cost, 2024
$920K
2,384 prescriptions
Company payments, 2025
$91.77
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bogdan N Cherascu was code J3262 (injection, tocilizumab, 1 mg), 162,400 times for 46 patients. In total Bogdan N Cherascu billed 247,806 services in 106 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 162,400 | 46 | $4.70 | $763K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 26,400 | 34 | $9.04 | $239K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 13,675 | 25 | $33.77 | $462K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 11,130 | 12 | $8.49 | $94K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 6,570 | 34 | $24.85 | $163K |
| J9312 Injection, rituximab, 10 mg | Office | 3,190 | 19 | $59.62 | $190K |
| J0897 Injection, denosumab, 1 mg | Office | 1,500 | 18 | $20.44 | $31K |
| 85652 Clinical Chemistry | Office | 1,125 | 372 | $2.65 | $2,981 |
| 86140 Clinical Chemistry | Office | 1,117 | 369 | $5.08 | $5,674 |
| 82565 Clinical Chemistry | Office | 1,095 | 367 | $5.02 | $5,497 |
| 85025 Blood Count | Office | 1,076 | 345 | $7.61 | $8,188 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,040 | 14 | $0.09 | $90.3 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 901 | 29 | $0.22 | $202 |
| 84450 Clinical Chemistry | Office | 639 | 158 | $5.08 | $3,246 |
| 84460 Clinical Chemistry | Office | 637 | 159 | $5.19 | $3,306 |
By year: 2022 $2.2M for 211,627 services; 2023 $2.5M for 251,084 services; 2024 $2.4M for 247,806 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85652 Clinical Chemistry | 1,125 | 372 | $2.65 | $2,981 |
| 86140 Clinical Chemistry | 1,117 | 369 | $5.08 | $5,674 |
| 82565 Clinical Chemistry | 1,095 | 367 | $5.02 | $5,497 |
| 85025 Blood Count | 1,076 | 345 | $7.61 | $8,188 |
| 84450 Clinical Chemistry | 639 | 158 | $5.08 | $3,246 |
| 84460 Clinical Chemistry | 637 | 159 | $5.19 | $3,306 |
| 36415 Venipuncture Blood Collection | 506 | 340 | $8.65 | $4,377 |
| 84520 Clinical Chemistry | 496 | 256 | $3.87 | $1,920 |
| 80076 Clinical Chemistry | 378 | 194 | $8.01 | $3,028 |
| 82310 Clinical Chemistry | 336 | 166 | $5.06 | $1,700 |
Medicare prescription drug claims, 2024
In 2024, the drug Bogdan N Cherascu prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 495 prescriptions and refills. In total Bogdan N Cherascu wrote 2,384 Medicare prescriptions that cost $920K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 495 | 1,200 | 159 | $20K |
| Methotrexate Methotrexate Sodium | 366 | 872 | 116 | $10K |
| Allopurinol Generic | 224 | 414 | 42 | $951 |
| Prednisone Generic | 149 | 180 | 82 | $1,074 |
| Methotrexate Sodium Methotrexate Sodium/Pf | 147 | 241 | 36 | $2,409 |
| Alendronate Sodium Generic | 124 | 281 | 43 | $592 |
| Gabapentin Generic | 120 | 214 | 38 | $1,501 |
| Leflunomide Generic | 113 | 255 | 40 | $6,501 |
| Azathioprine Generic | 51 | 99 | 13 | $2,687 |
| Folic Acid Generic | 51 | 159 | 20 | $480 |
| Colchicine Generic | 40 | 48 | 19 | $886 |
| Duloxetine Hcl Generic | 38 | 80 | 14 | $688 |
| Sulfasalazine Dr Sulfasalazine | 37 | 71 | 12 | $2,048 |
| Febuxostat Generic | 28 | 44 | Under 11 | $1,795 |
| Xeljanz Xr Tofacitinib Citrate | 28 | 28 | Under 11 | $169K |
Brand drugs: 215 claims; generic drugs: 2,158 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bogdan N Cherascu $91.77 ($91.77 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $91.77.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $91.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.